Stay updated on Cabozantinib and Durvalumab Immuno-oncology Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study page now returns a 403 Forbidden error, replacing the previously visible trial details with an access-denied message. This blocks access to core information about the trial, including its status, eligibility, locations, and contacts.
    Difference
    20%
    Check dated 2026-09-22T23:21:18.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page revision has been upgraded from v3.6.6 to v3.7.0, indicating a new version of the page. This update likely includes minor adjustments to layout or content without changing the core study information.
    Difference
    0.1%
    Check dated 2026-09-15T22:12:47.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing Revision: v3.6.5, indicating a minor version update to the page’s template or underlying platform.
    Difference
    0.1%
    Check dated 2026-09-01T19:39:22.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.5, signaling a minor update to the page. This change represents a backend or UI update rather than a modification to study details.
    Difference
    0.1%
    Check dated 2026-08-11T16:22:52.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a small backend/UI update that does not affect the study details or displayed information.
    Difference
    0.1%
    Check dated 2026-07-28T05:23:39.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a small maintenance update to the page's documentation or rendering.
    Difference
    0.1%
    Check dated 2026-07-06T18:19:05.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Durvalumab Immuno-oncology Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.